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INTRODUCTION
Thoracotomy causes severe postoperative pain and a marked
impairment of deep breathing and coughing which leads to
postoperative complications such as atelectasis, hypoxemia,
pneumonia, and respiratory insufficiency (1). Effective anal-
gesia to minimize the impairment of respiratory function and
to prevent respiratory complications is mandatory. The most
effective analgesic methods known for post-thoracotomy pain
are epidural local anesthetic-opiate combinations and paraver-
tebral analgesia (2, 3). However, it is necessary to use other
analgesic methods such as intravenous opiate or cryoanalge-
sia in some patients who refuse epidural catheterization or in
whom epidural catheterization is impossible because of ana-
tomic abnormalities.
Intravenous opiate is simple and rapid in onset, but can
cause nausea, vomiting, pruritus and respiratory depression
because of the narrow therapeutic-respiratory depression win-
dow (4). Cryoanalgesia is relatively safe, effective and long
lasting, but may be ineffective against pain mediated by the
phrenic, vagus or the sympathetic nerves (4, 5), and it takes
5-11 days to achieve the analgesic effect (3, 6). Many investi-
gators have reported upon the effect of cryoanalgesia in post-
thoracotomy pain versus intravenous opiate, thoracic epidu-
ral, transcutaneous nerve stimulation (TENS), and interpleu-
ral analgesia (5-8). The reports about the efficacy of cryoanal-
gesia have been controversial. The analgesic efficacy of cryo-
analgesia has been reported to be similar to or less than intra-
venous opiate and to be less than thoracic epidural (3, 5, 6,
8-10). One study found that cryoanalgesia could cause neu-
ralgia (11), but thoracotomy itself carries a risk of producing
intercostal neuralgia (12), and cryotherapy is one of the treat-
ment modality for neuralgia in chronic pain management (13).
Jones and Murrin treated patients suffered from a long-term
post-thoracotomy pain by transcutaneous cryoanalgesia and
reported that the pain was relieved or reduced in 70% of
patients and the duration of pain relief was considerably longer
(14). The efficacy of cryoanalgesia needs to be verified and no
report is available upon the effect of cryoanalgesia combined
with other analgesic methods.
It has been reported that preemptive analgesia or aggres-
sive management of early postoperative pain can reduce the
incidence of long-term post-thoracotomy pain (15, 16), but
no study has reported upon whether long lasting cryoanalge-
sia can reduce its incidence. 
Therefore, we undertook a study on the effects of cryoanalge-
sia combined with intravenous continuous analgesia (IVCA)
in thoracotomy patients in whom thoracic epidural was refused
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Effect of Cryoanalgesia Combined with Intravenous Continuous
Analgesia in Thoracotomy Patients
Fifty patients undergoing thoracotomy was studied to compare the effects of cryo-
analgesia combined with intravenous continuous analgesia (IVCA). Patients were
randomized into two groups: IVCA group and IVCA-cryo group. Subjective pain inten-
sity was assessed on a visual analogue scale at rest (VAS-R) and during movement
(VAS-M). Analgesic requirements were evaluated over the 7 days following surgery.
Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) were mea-
sured before operation, on the 2nd and 7th postoperative days (POD). We interviewed
patients by telephone to evaluate the prevalence of post-thoracotomy pain at the 1st,
3rd, and 6th months postoperatively. No significant differences were observed be-
tween the two groups with respect to postoperative pain, analgesic requirements,
side effects, respiratory complications, or prevalence of post-thoracotomy pain. How-
ever, a significant increase in FVC and FEV1 was observed on the 7th POD in IVCA-
cryo group. The incidence of the post-thoracotomy pain at the 1st, 3rd, and 6th months
postoperatively was 68, 60, and 44% in IVCA group, and 88, 68, and 28% in IVCA-
cryo group, respectively. Our study showed that cryoanalgesia combined with IVCA
effectively restore respiratory function on 7th POD, but that it was not effective at reduc-
ing the incidence of post-thoracotomy pain.
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or impossible. We studied whether this combination of the
two methods (prompt onset and systemic analgesic effect from
IVCA and the long-lasting analgesic effect of cryoanalgesia)
could provide additive effects in terms of pain score and res-
piratory function test improvement, in an effort to reduce
both the requirements for analgesics and respiratory compli-
cations during the acute postoperative period. In addition,
we wanted to determine whether such a combination could
reduce the incidence of long-term post-thoracotomy pain and
whether it caused neuralgia.
MATERIALS AND METHODS
Fifty patients who underwent posterolateral thoracotomy
for lung cancer were studied. Patients were excluded if they
had preoperative respiratory dysfunction, were scheduled for
elective postoperative mechanical ventilation, or had been
receiving analgesics for chronic pain. All patients gave writ-
ten informed consent to the trial that was approved by our
hospital’s Ethics Committee. Patients were randomized into
two groups: an IVCA group and an IVCA-cryo group. There
was no significant difference between the two groups in terms
of age, sex, body weight, height, or distributions of surgeons
or operations (Table 1). 
General anesthesia was induced with thiopental 5 mg/kg
and vecuronium 0.1 mg/kg to facilitate tracheal intubation
with a double-lumen endobronchial tube. Anesthesia was
maintained with enflurane 0-4 vol% inspired in oxygen with
one-lung ventilation. Muscular relaxation was achieved by
intermittent injection of vecuronium. Before the surgical inci-
sion, a bolus of fentanyl 2  g/kg and ketorolac 0.2 mg/kg was
administered to patients in both groups intravenously, and
continuous infusion was started at a rate of 0.5 mL/hr using an
infuser (Portable Elastometric Infusion System, Baxter Health-
care Corporation, U.S.A.). The infuser contained fentanyl 30
g/kg and ketorolac 3 mg/kg in 60 mL of normal saline.
Before thorax closure, three intercostal nerves were frozen
in each patient in the IVCA-cryo group, using a nitrous oxide
cryoprobe (SL 2000 Lloyd Neurostat, Spembly Medical Ltd.,
U.K.) at -20℃ for a 90 sec under direct vision. Nerves were
dissected out as far back as possible to include the collateral
branches, and were frozen at the operative level, and at one
level above and below the incision after peeling back the pleu-
ra. A 10-sec thaw was allowed prior to probe removal in order
to prevent nerve adherence. 
Severity of pain was graded by the patients on a 10 cm VAS
chart, one mark representing pain at rest (VAS-R) and the
other pain on deep breathing and coughing (VAS-M). The
VAS score was recorded daily until the 7th postoperative day
(POD) and breakthrough pain when experienced by patients
was treated with 0.6  g/kg of fentanyl intravenously on de-
mand. We investigated the required doses and numbers of
fentanyl treatments, and asked about the presence and frequen-
cies of nausea, vomiting and pruritus and also checked the
incidence of respiratory depression (less than 10/min of the
respiratory rate). 
Forced vital capacity (FVC) and forced expiratory volume
in one second (FEV1) were recorded preoperatively, 2nd and
7th POD by a research assistant using a portable spirometer
(Micro, Micro Medical Ltd, Rochester, England). Three spiro-
metric measurements were taken while the patient was sitting
upright and the means of these measurements were included
Values are mean±SD or numbers of patients. IVCA, intravenous con-
tinuous analgesia; IVCA-cryo, intravenous continuous analgesia com-
bined with cryoanalgesia; L/P, lobectomy/pneumonectomy. There was
no significant difference between the two groups.
Age (yr) 60.6±10.1 58.6±9.5
Sex (male/female) 16/9 19/6
Weight (kg) 62.6±8.7 62.1±8.8
Height (cm) 161.0±8.6 163.3±6.4
Surgeons (A/B) 18/7 16/9
Operations (L/P) 23/2 22/3
Table 1. Demographic data
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Fig. 1. Visual analogue scale at rest and during movement show no difference between the two groups. Data expressed as mean±SD.76 M.S. Gwak, M. Yang, T.S. Hahm, et al.
in the analysis. We checked the chest radiograph on the 2nd
and 7th POD and recorded the incidence of atelectasis, effu-
sion, and pneumonia. Patients who required the assistance
of a mechanical ventilator because of respiratory insufficiency,
and who received talc pleurodesis because of a consistent air
leak during the postoperative period were excluded.
Patients were contacted by telephone on the 1st, 3rd, and
6th months postoperatively by a research assistant. A standard-
ized questionnaire was administered to each patient, which
assessed the absence or presence and intensity of pain and
numbness in the region of the thoracotomy scar at rest and
during deep breathing and coughing. All patients reporting
pain rated it on a 0-10 numerical rating scale (NRS).
Using a double blind method, research assistant and nurses
were unaware of the patient group assignments. 
Inter-group demographics and difference in the incidence
of side effects, respiratory complications and long-term post-
operative pain and numbness were compared using the t-test
and the chi-square test, respectively. For VAS scores, analgesic
requirements and spirometry data, repeated measures analy-
sis of variance and Dunnet’s test were used for intra-group
comparisons, and the Mann-Whitney rank sum test with Bon-
ferroni’s correction was used for inter-group comparisons. A
p value<0.05 was taken to indicate a significant difference.
Data are presented as means±SD or as numbers of patients.
RESULTS
No statistically significant difference was found between
the two groups with respect to VAS-R or VAS-M (Fig. 1), and
the groups were similar in terms of analgesics requirements
(Fig. 2). FVC and FEV1 increased significantly in IVCA-cryo
group on the 7th POD (Fig. 3). On the contrary, FVC and
FEV1 on the 2nd POD was slightly lower in IVCA-cryo group
than in IVCA group, but this difference was not statistically
significant. The incidence of pruritus, nausea, vomiting, atelec-
tasis, pneumonia and effusion was similar in the two groups
(Table 2).
The incidence of long-term post-thoracotomy pain and
numbness in the 1st, 3rd, and 6th months was shown in Table
3. NRS-R and NRS-M in the 1st, 3rd, and 6th months were
2.1/3.9, 1.5/2.6, and 1.3/2.2 in the IVCA group and 1.6/3.4,
1.1/2.7, and 0.8/1.8 in the IVCA-cryo group, respectively.
There was no statistical difference during the entire observa-
tion period between the two groups. 
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Fig. 2. Analgesics requirement shows no difference between the
two groups. Data expressed as mean±SD.
Fig. 3. Forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) on the 7th POD are significantly increased in the IVCA-cryo
group. Data expressed as mean±SD. *; p<0.05 versus the preoperative value. 
� ; p<0.05 versus the IVCA group.
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Values are number of patients. IVCA, intravenous continuous analgesia;
IVCA-cryo, intravenous continuous analgesia combined with cryoanalge-
sia. There was no significant difference between the two groups.
Pruritus 3 1
Nausea/vomiting 8 5
Atelectasis 2 3
Pneumonia 0 1
Effusion 2 3
Table 2. Incidence of side effects and complications
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DISCUSSION
Cryoanalgesia was introduced as a mean of achieving pain
relief after the development of the first cryoprobe in 1961 by
Cooper, and the demonstration by Lloyd that prolonged anal-
gesia could be obtained following a single freeze of a periph-
eral nerve. Lloyd et al. (17) stressed the safety aspect of the
procedure and reported that nerve function always returned
and neuroma formation did not occur. 
When nerve fibers are progressively cooled, the dissociation
of sensory modalities and a loss of motor function often occurs
above 10℃, complete temporary conduction block occurs at
temperatures between 0℃ and -20℃, and at temperatures
below -20℃, persistent conduction block occurs and recovers
with axonal regeneration (7). Zhou et al. (18) reported that
cryotherapy at -60℃ to -100℃ injured myelinated fibers
selectively, but complete regeneration occurred within 60 days.
These workers felt that the technique might be suitable for
short period analgesia for postoperative pain. Moreover, cryo-
lesioning at -140℃ to -180℃ caused complete nerve fiber
necrosis with subsequent incomplete regeneration, which
might be suitable for lasting pain relief in those with intracta-
ble pain.
According to Evans et al. (19), once the critical temperature
of -20℃ has been reached in tissues, no additional benefit is
derived by prolonging the duration of exposure or by repeat-
ing the freeze thaw cycle. Moreover, to inhibit saltatory con-
duction for myelinated fibers, a lesion of 3 mm diameter will
suffice, and this can be achieved by a 1 min freeze (7, 19). Lloyd
et al. (17) advocated two freeze cycles of 2 min’ each, whereas
Wood et al. (20) recommended two 1-min freezes, though
Katz et al. (21) achieved good results after a 1 min freeze. In
patients who receive transcutaneous cryoanalgesia, close app-
roximation between the cryoprobe and the nerves may be dif-
ficult, and repeated cycles might be necessary. In the present
study, we performed cryoanalgesia under direct vision and
considered one 90 sec at -20℃freeze sufficient.
The efficacy of cryoanalgesia remains controversial. Several
studies have demonstrated that it is less effective than epidural
analgesia (2, 3, 8-10), though its effect was found to be sim-
ilar to intravenous morphine (5), whereas Muller et al. (11)
found that it has no analgesic effect and causes moderate to
severe neuralgiform pain. However, none of the patients in
the present study complained of symptoms suggestive of severe
neuralgic pain. Katz et al. (21) reported that patients under-
went thoracotomy and who received cryoanalgesia had less
postoperative pain and that their requirements for analgesics
were reduced by 50% versus those who did not receive the
cryoanalgesia, and that a return of sensation occurred within
30 days. Moreover, patients receiving cryoanalgesia were found
not to perform well on the 1st POD, but by the 5th POD,
cryoanalgesia was found to be significantly effective at man-
aging post-thoracotomy pain (6). According to Brichon et al.
(3) cryoanalgesia provided a slight improvement in postop-
erative pain and marginally reduced analgesic requirements
in the early PODs, but achieved a better pain score than epidu-
ral analgesia on the 11th and 12th PODs. 
Our results showed that cryoanalgesia combined on IVCA
had no effect in terms of reducing analgesic requirements or
upon improving pain score, but it did improve the respiratory
function test results on the 7th POD. Moreover, these results
were comparable with the results of Rooney et al. (6) in terms
of the delayed onset of the effect. But it is questionable that
pain score and analgesic requirements did not show the same
improvement. We thought that was because much of the pain
in thoracotomy came from straining of the ligaments during
rib retraction and such pain was mediated by posterior primary
rami, which were not affected by intercostal nerve freezing. 
We interviewed patients on the 1st, 3rd, and 6th months
postoperatively by telephone to determine whether cryoanal-
gesia could prevent or reduce the incidence of post-thoraco-
tomy pain. In our study, the incidences of long-term post-tho-
racotomy pain were 68%, 60%, and 44% in the IVCA group
and 88%, 68%, and 28% in the IVCA-cryo group on the 1st,
3rd, and 6th months, which suggests that cryoanalgesia is
not helpful at preventing or reducing post-thoracotomy pain.
Although it was not statistically significant, the incidence of
long-term post-thoracotomy pain was even higher in IVCA-
cryo group than in IVCA group on the 1st and 3rd months.
Long-term pain scores in the IVCA-cryo group were slightly
lower than those in the IVCA group, but this difference was
statistically insignificant. 
Katz et al. (16) followed up 30 thoracotomy patients by tele-
phone over 1.5 yr in an effort to identify predictors of long-
term post-thoracotomy pain and reported that early postop-
erative pain was the only significant predictor, and that pre-
emptive analgesia or analgesic requirements did not produce
significant difference. They concluded that aggressive man-
agement of early postoperative pain might reduce the likeli-
hood of long-term post-thoracotomy pain. 
Post-thoracotomy pain syndrome (PTPS), which recurs or
persists along the thoracotomy incision over at least the first
postoperative 2 months is influenced by extent of the incision,
muscle sparing versus dividing, rib resection, and video-assist-
ed thoracic surgery versus thoracotomy. Prevention is the best
Values are numbers (%) of patients. IVCA, intravenous continuous analge-
sia; IVCA-cryo, intravenous continuous analgesia combined with cryoanal-
gesia. There was no significant difference between the two groups.
Pain 1 month 17 (68) 22 (88)
3 months 15 (60) 17 (68)
6 months 11 (44) 7 (28)
Numbness 1 month 18 (72) 20 (80)
3 months 13 (52) 18 (72)
6 months 7 (28) 9 (36)
Table 3. Long-term follow-up
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strategy, and aggressive management of early postoperative
pain and preemptive analgesia are important in prevention,
and ketamine, an NMDA antagonist is known as useful in
its treatment (22). Overall incidences of PTPS ranged wide-
ly from 2% to 67% because of the varying definitions uses
for PTPS and the diversity of operating procedures and anal-
gesic methods. Kalso et al. (12) reported that the incidence
of persistent post-thoracotomy pain lasting for more than 6
months was 44%. In the study of Dajczman et al. (23), 30%
of patients suffered pain for more than four years post-thora-
cotomy, and the pain was generally not severe, but a small
percentage of patients experienced persistent, moderately
disabling pain. In our study, on the 3rd month, 60%, and 68%
of patients suffered pain in the IVCA and in the IVCA-cryo
group, and on the 6th month, 44%, and 28% of patients expe-
rienced pain. Though this pain was mild, less than three by
the NRS, the combination of cryoanalgesia did not reduce
its incidence. 
More than 2/3 of patients in the IVCA and IVCA-cryo
groups complained of numbness around the incision area on
the 1st month, and this proportion decreased to 28% and
36% on the 6th month, respectively. No significant difference
between the two groups were evident, thus it is presumed
that the numbness was caused not only by the cryoanalgesia
but also by nerve injury during rib resection. 
Conclusively, cryoanalgesia combined with IVCA improved
respiratory function partially, but had no ameliorative effect
on pain scores and did not reduce analgesics requirement dur-
ing the acute postoperative period. Moreover, it failed to reduce
the incidence of long-term post-thoracotomy pain, but did
not cause neuralgic pain.
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